WILLIAM WONG to Prognosis
This is a "connection" page, showing publications WILLIAM WONG has written about Prognosis.
Connection Strength
0.253
-
Cost-Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma. Oncologist. 2018 02; 23(2):225-233.
Score: 0.070
-
Factors Associated With Survival Following Radium-223 Treatment for Metastatic Castration-resistant Prostate Cancer. Clin Genitourin Cancer. 2017 12; 15(6):e969-e975.
Score: 0.068
-
Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy. Pediatr Nephrol. 2013 Dec; 28(12):2313-21.
Score: 0.053
-
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update. BMJ Open. 2019 11 11; 9(11):e027491.
Score: 0.020
-
Low Levels of Energy Expenditure in Childhood Cancer Survivors: Implications for Obesity Prevention. J Pediatr Hematol Oncol. 2015 Apr; 37(3):232-6.
Score: 0.015
-
Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol. 2014 Aug; 15(9):1027-38.
Score: 0.014
-
Outcomes in a multi-institutional cohort of patients treated with intraoperative radiation therapy for advanced or recurrent renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):618-23.
Score: 0.014